Not logged inReal-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial
Ahn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia .png)
Share.png)
SaveUtilizing the DMN and DAN to Study the Effects of Acupuncture on Patients with Cognitive Impairment in Long COVID: A Pragmatic Randomized Controlled Trial ProtocolChen, Jing; Wu, Yanyu; Zhang, Ziang; Shen, Mengru; Zhou, Yang; Zhang, Han; Zhuang, Zesen; Wang, Shiqi; Wang, Dan; Xu, Lei; Lu, Yingqi; Chen, Shangjie Share Save Share Save Share Save Share Save Share Save Share Save Indirect comparisons of brigatinib and alectinib for front-line ALK-positive non-small-cell lung cancerReckamp, Karen L.; Lin, Huamao M.; Cranmer, Holly; Wu, Yanyu; Zhang, Pingkuan; Walton, Laura J.; Kay, Stephen; Cichewicz, Allie; Neupane, Binod; Fahrbach, Kyle; Popat, Sanjay; Camidge, D. Ross Share Save Share Save Share Save Expression and clinical significance of CXC chemokines in the glioblastoma microenvironmentLi, Chenglin; Deng, Hanshun; Zhou, Yanfei; Ye, Yuanshen; Zhao, Shuizhen; Liang, Shangnan; Cai, Shirong; Lin, Jincai; Tang, Yaolong; Wu, Yanyu Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
